GOVX logo

GeoVax Labs, Inc. New


GOVX: Geovax Labs Inc is a clinical-stage biotechnology company developing human vaccines and immunotherapies against infectious diseases and solid tumor cancers using novel proprietary platforms. GeoVax's product pipeline includes ongoing human clinical trials for a next-generation COVID-19 vaccine and a gene-directed therapy against head and neck cancers. Additional research and development programs include preventive vaccines against Monkeypox (MPox), hemorrhagic fever viruses (Ebola Zaire, Ebola Sudan, Marburg, and Lassa), and Zika virus, as well as immunotherapies for multiple solid tumors.


Show GOVX Financials

Consumer Interest
SEC Filings

Recent trades of GOVX by members of U.S. Congress

Quiver Logo

No Congress Trading data for this ticker

Congress Trading Dashboard

Recently reported changes by institutional investors

Quarterly net insider trading by GOVX's directors and management

Government lobbying spending instances

  • $5,000 Jul 14, 2016 Issue: Health Issues
U.S. Patents

New patents grants

Quiver Logo

No new patents for this ticker

U.S. Patents Dashboard
Government Contracts

Federal grants, loans, and purchases

Quiver Logo

No Government Contracts for this ticker

Government Contracts Dashboard

Number of mentions of GOVX in WallStreetBets Daily Discussion


Recent insights relating to GOVX

CNBC Recommendations

Recent picks made for GOVX stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in GOVX

Corporate Flights

Flights by private jets registered to GOVX